2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p [q] r s t u v w x y z

QPS over the supplementary motor area induced cortical excitability changes in human primary motor cortex: Comparison with Placebo effect

K. Sato, M. Hamada, Y. Shirota, S. Kodama, Y. Sugiyama, Y. Ugawa, C. Hosoda, T. Toda (Tokyo, Japan)
Quality of life in isolated dystonia – a cross-sectional study

J. Junker, B. Berman, D. Wahba, J. Hall, J. Perlmutter, J. Jankovic, I. Malaty, V. Brandt, S. Reich, A. Espay, N. Patel, E. Roze, M. Vidailhet, H. Jinnah, N. Brueggemann (Luebeck, Germany)
Quality of Life Indicators and Psycho-Social Adaptation of Patients with Essential Tremor

A. Taskinbayeva (Almaty, Kazakhstan)
Quantification of regional iron content with Susceptibility Weighted Imaging in Huntington Disease Expansion Gene Carriers

ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)
Quantifying eye and gait abnormalities in Parkinson’s patients after Deep brain stimulation

Z. Su, M. Brzezick, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Quantifying gait parameters in Parkinson’s disease patients who do and do not exhibit freezing of gait.

K. Kwei, A. De-La Mora, D. Payne, D. Tomishon, S. Agrawal, N. Vanegas-Arroyave (New York, NY, USA)
Quantitative Assessment of Saccadic Eye Movements in Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease

C. Fearon, Y. Llamas-Osorio, L. Williams, A. Laffan, P. Moloney, R. Field, R. Reilly, T. Lynch (Dublin, Ireland)
Quantitative assessments better delineate rare disease: reconsidering the diagnostic criteria in ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP)

I. Haq, B. Snively, K. Sweadner, C. Suerken, J. Cook, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)
Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)
Quantitative evaluation of gait ataxia of Multiple System Atrophy patients

C. Sato, S. Shirai, M. Matsushima, I. Yabe, H. Sasaki (Sapporo, Japan)
Quantitative Gait Assessment of Patients with Essential Tremor Using Wireless Sensors

V. Sharma, S. Moon, H. Devos, K. Lyons, R. Pahwa (Kansas City, KS, USA)
Quantitative Motor (Q-Motor) Assessments Suggest a Beneficial Central Effect of Laquinimod in a Phase II Study in Huntington Disease (LEGATO-HD)

R. Reilmann, M. Gordon, R. Schubert, K. Anderson, A. Feigin, S. Tabrizi, B. Leavitt, J. Stout, P. Piccini, B. Borowsky, G. Rynkowski, R. Volkinshtein, J. Savola, M. Hayden (Muenster, Germany)
Quantitative straight and circular walking parameters for detecting ON and OFF medication states in early PD

MF. Corrà, N. Vila-Chã, J. Damasio, S. Duarte, A. Sardoreira-Bràs, P. Salgado, M. Calejo, C. Hansen, H. Minh Pham, R. Magalhães, M. Correia, W. Maetzler, L. Maia (Porto, Portugal)
Quantitative study of subthalamic ERG potassium channels in parkinsonian discharges

C. Mahapatra, R. Manchanda (Mumbai, India)
Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition

LX. Xue, EH. Xu, JK. Li, Q. Yang, P. Chan (Beijing, China)
Quercetin administration abrogates the Parkinson’s disease (PD)-like motor and non-motor symptoms and attenuates the behavioral, neurochemical and biochemical deficits induced by rotenone toxicity in rats

S. Madiha, S. Haider (Karachi, Pakistan)
Quercetin Regulates Cadmium Induced Motor Dysfunction in Depletion of Dopamine and its Metabolites at Synapse

R. Gupta, RK. Shukla, AB. Pant, VK. Khanna (Lucknow, India)

Jump to: View All • a b c d e f g h i j k l m n o p [q] r s t u v w x y z